Clinical Trial Update: Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the addition of rosiglitazone (Avandia) to submaximal-dose metformin in adults with Type 2 diabetes to assess efficacy and tolerability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED